Skip to content

Feasibility of Providing Computerized CBT in the Black Church

A Pilot Feasibility Study of Providing Substance Use Treatment in the Black Church

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03579290
Enrollment
40
Registered
2018-07-06
Start date
2018-05-24
Completion date
2018-10-30
Last updated
2024-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Abuse

Brief summary

The investigator will conduct a pilot study evaluating the feasibility and acceptability of providing a computer-based program (CBT4CBT), used for the treatment of substance use disorders, in a church setting.

Detailed description

The investigator will conduct a pilot study evaluating the feasibility and acceptability of providing a computer-based program (CBT4CBT), used for the treatment of substance use disorders, in a church setting. Forty Black adults with a current DSM-5 alcohol or substance use disorder will utilize the 'CBT for CBT' program over a period of 8 weeks. Primary outcomes will be acceptability and feasibility of providing the treatment in a church setting. If found to be acceptable and feasible, with preliminary promise for reductions in substance use, the next step would be to adapt the computer intervention for this population and conduct a randomized controlled trial.

Interventions

BEHAVIORALCBT4CBT program

The 'CBT for CBT' program is modeled closely on our NIDA-published CBT manual. Seven core skill modules will cover the following topics, which correspond to the major session topics in the manual: * Understanding and changing patterns of drug use, * Coping with craving, * Substance refusal skills, * Seemingly irrelevant decisions, * Planning for emergencies, and * Problem-solving skills. * Staying Safe

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Yale University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At least 18 years of age * Has at least one SUD diagnosis as defined by the DSM 5

Exclusion criteria

* Are unable provide informed consent or participate in the study procedures as proposed in the consent * Active suicidal or homicidal ideation * Current engagement in substance use treatment * Have a current legal case pending, such that incarceration during the 8 week protocol is likely * Are in need of detoxification from alcohol, opioids or benzodiazepines

Design outcomes

Primary

MeasureTime frameDescription
Recruitment Feasibility8 weeksFeasibility is a composite variable (yes/no indicator). This will be determined by counting the number of participants completing the CBT4CBT intervention with significant reductions in drug use, as measured by mean change scores in the severity and quantity of substance use, and functioning over the course of treatment.
Program Acceptability8 weeksAcceptability of treatment will be assessed by giving each participant a post-intervention satisfaction survey that assesses satisfaction with the intervention, perception of outcome, attitudes about spiritual practices accompanying CBT4CBT modules, and whether the participant would recommend this program to a friend. To evaluate the acceptability of CBT4CBT with BSUD in a church setting and to identify if religious behaviors led by trained church based health advisors (CHA), may increase the likely suitability of this intervention within the Black church.
Sessions Attended8 weeksTo determine the feasibility of the program, the mean number of sessions attended was calculated per participant. The maximum number of sessions that could be attended was 7. A missed session could be made up in an additional week. The program lasted 8 weeks.

Countries

United States

Participant flow

Recruitment details

Recruitment occurred June through August of 2018. Participants were recruited from flyers distributed at local churches and from community services in the New Haven area. The flyers were developed with the Yale Center for Clinical Investigation (YCCI) to be culturally appropriate, and featured images of Black adults.

Participants by arm

ArmCount
CBT4CBT Program
The 'CBT for CBT' program is modeled closely on our NIDA-published CBT manual. Seven core skill modules will cover the following topics, which correspond to the major session topics in the manual: Understanding and changing patterns of drug use, Coping with craving, Substance refusal skills, Seemingly irrelevant decisions, Planning for emergencies, and Problem-solving skills. Staying Safe CBT4CBT program: The 'CBT for CBT' program is modeled closely on our NIDA-published CBT manual. Seven core skill modules will cover the following topics, which correspond to the major session topics in the manual: * Understanding and changing patterns of drug use, * Coping with craving, * Substance refusal skills, * Seemingly irrelevant decisions, * Planning for emergencies, and * Problem-solving skills. * Staying Safe
40
Total40

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up9

Baseline characteristics

CharacteristicCBT4CBT Program
Age, Continuous51.9 years
STANDARD_DEVIATION 9.7
DSM 5 checklist for substance use disorders
Mild
5 Participants
DSM 5 checklist for substance use disorders
Moderate
13 Participants
DSM 5 checklist for substance use disorders
Severe
22 Participants
Number of Participants Testing Positive for Substance
Number of positive for Alcohol
16 Participants
Number of Participants Testing Positive for Substance
Number positive for Amphetamine
1 Participants
Number of Participants Testing Positive for Substance
Number positive for Barbiturates
2 Participants
Number of Participants Testing Positive for Substance
Number positive for Benzodiazapines
0 Participants
Number of Participants Testing Positive for Substance
Number positive for Buprenorphine
2 Participants
Number of Participants Testing Positive for Substance
Number positive for Cocaine
22 Participants
Number of Participants Testing Positive for Substance
Number positive for Ecstasy
3 Participants
Number of Participants Testing Positive for Substance
Number positive for Marijuana
16 Participants
Number of Participants Testing Positive for Substance
Number positive for Methadone
2 Participants
Number of Participants Testing Positive for Substance
Number positive for Methamphetamine
0 Participants
Number of Participants Testing Positive for Substance
Number positive for Opioids
4 Participants
Number of Participants Testing Positive for Substance
Number positive for Oxycodone
2 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
40 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
0 Participants
Region of Enrollment
United States
40 Participants
Sex: Female, Male
Female
20 Participants
Sex: Female, Male
Male
20 Participants
Substance Use Calendar
Mean days of alcohol use past 28 days
17.9 days
STANDARD_DEVIATION 10.3
Substance Use Calendar
Mean days of benzodiazapine use past 28 days
.31 days
STANDARD_DEVIATION 1.3
Substance Use Calendar
Mean days of cocaine use past 28 days
8.9 days
STANDARD_DEVIATION 11.9
Substance Use Calendar
Mean days of heroin use past 28 days
3.0 days
STANDARD_DEVIATION 8
Substance Use Calendar
Mean days of marijuana use past 28 days
7.6 days
STANDARD_DEVIATION 10.6
Substance Use Calendar
Mean days opioid use past 28 days
1.3 days
STANDARD_DEVIATION 5
Substance Use Calendar
Mean number of days of nicotine use past 28 days
13.2 days
STANDARD_DEVIATION 13

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 40
other
Total, other adverse events
0 / 40
serious
Total, serious adverse events
0 / 40

Outcome results

Primary

Program Acceptability

Acceptability of treatment will be assessed by giving each participant a post-intervention satisfaction survey that assesses satisfaction with the intervention, perception of outcome, attitudes about spiritual practices accompanying CBT4CBT modules, and whether the participant would recommend this program to a friend. To evaluate the acceptability of CBT4CBT with BSUD in a church setting and to identify if religious behaviors led by trained church based health advisors (CHA), may increase the likely suitability of this intervention within the Black church.

Time frame: 8 weeks

Population: Participants that completed the program.

ArmMeasureGroupValue (MEAN)Dispersion
CBT4CBT ProgramProgram AcceptabilityOverall Satisfaction (1-5) Very satisfied to very dissatisfied1.6 units on a scaleStandard Deviation 0.89
CBT4CBT ProgramProgram AcceptabilityDescribe current condition at present (1-5) excellent to poor1.7 units on a scaleStandard Deviation 0.66
CBT4CBT ProgramProgram AcceptabilityHow have you changed (1-5) much worse to much better better3.8 units on a scaleStandard Deviation 1.2
CBT4CBT ProgramProgram AcceptabilityAre you worse, unchanged or better (1-3)2.6 units on a scaleStandard Deviation 3.8
CBT4CBT ProgramProgram AcceptabilityAre you better due to tx in Black Church (1-5) Definitely not related to definitely related3.1 units on a scaleStandard Deviation 1.5
CBT4CBT ProgramProgram AcceptabilitySatisfaction with amount of tx received (1-5) very satisfied to very dissatisfied1.9 units on a scaleStandard Deviation 1.2
CBT4CBT ProgramProgram AcceptabilityHow satisfied were you with the CBT program (1-6) very satisfied to very dissatisfied1.6 units on a scaleStandard Deviation 1
CBT4CBT ProgramProgram AcceptabilityIf seeking future tx, would you return to CBT program (1-5) Definitely to definitley not1.4 units on a scaleStandard Deviation 0.72
CBT4CBT ProgramProgram AcceptabilityHas this tx program met your need (1-5) almost all needs to none of my needs2.1 units on a scaleStandard Deviation 1.1
CBT4CBT ProgramProgram AcceptabilityWhat will be drug and alcohol use in the next month (1-6) not use any to use daily2.0 units on a scaleStandard Deviation 1.3
CBT4CBT ProgramProgram AcceptabilityAble to do homework after watching example (1-5) strongly disagree to strongly agree3.5 units on a scaleStandard Deviation 1.1
CBT4CBT ProgramProgram AcceptabilityHomework helped me understand my drug and alcohol use (1-6) strongly disagree to strongly agree4.0 units on a scaleStandard Deviation 1
CBT4CBT ProgramProgram AcceptabilityHomework helped give me tools to help drug problem (1-6) strongly disagree to strongly agree4.1 units on a scaleStandard Deviation 1.3
CBT4CBT ProgramProgram AcceptabilitySatisfied with general content of CBT program (1-5) strongly dissatisfied to strongly satisfied3.7 units on a scaleStandard Deviation 0.95
CBT4CBT ProgramProgram AcceptabilitySatisfied with ability to learn from CBT program (1-5) strongly dissatisfied to strongly satisfied3.7 units on a scaleStandard Deviation 1
CBT4CBT ProgramProgram AcceptabilityRating for computer facilitated program as tool for learning (1-5) very poor to excellent3.8 units on a scaleStandard Deviation 0.97
Primary

Recruitment Feasibility

Feasibility is a composite variable (yes/no indicator). This will be determined by counting the number of participants completing the CBT4CBT intervention with significant reductions in drug use, as measured by mean change scores in the severity and quantity of substance use, and functioning over the course of treatment.

Time frame: 8 weeks

Population: This outcome measure was never collected.

Primary

Sessions Attended

To determine the feasibility of the program, the mean number of sessions attended was calculated per participant. The maximum number of sessions that could be attended was 7. A missed session could be made up in an additional week. The program lasted 8 weeks.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
CBT4CBT ProgramSessions Attended6.8 sessionsStandard Deviation 1.9

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026